<DOC>
	<DOCNO>NCT00969839</DOCNO>
	<brief_summary>This post-market clinical study do evaluate use NovaLignâ„¢ Intramedullary Fixation System treatment humeral fracture .</brief_summary>
	<brief_title>NovaLign Intramedullary Fixation System ( IFS ) Treatment Humeral Fractures</brief_title>
	<detailed_description>This observational , prospective , nonrandomized open label , post-market clinical study , design evaluate use flexible intramedullary fixation device use treatment fracture humerus . This multicentre trial .</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<criteria>Humeral Fracture Surgical intervention perform within 14 day injury ( injury Day 0 particular criterion ) Fully function contralateral limb ( e.g. , hand , arm , shoulder ) Age 18 year old skeletally mature Intraarticular fracture involve shoulder elbow index arm Pathologic fracture ( e.g. , tumor involvement , osteomalacia , etc . ; osteoporosis exclusion ) Evidence neurologic injury index arm , include compartment syndrome radial nerve palsy Additional upper body injury ( e.g. , upper extremity , abdominal , thoracic , neck head injury ) may affect inhibit evaluation index contralateral arm , shoulder , elbow , etc would allow patient follow comply appropriate postoperative regimen Any previous bodily injury surgery may interfere function evaluation index contralateral arm , shoulder , elbow , etc .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Fracture</keyword>
	<keyword>Humerus</keyword>
	<keyword>Intramedullary</keyword>
	<keyword>Fixation</keyword>
</DOC>